← Leaderboards
Mark Douglas Okusa
University Of Virginia Charlottesville
$24,807,098
Attributed
$27,101,805
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,517,908 · 17
By mechanism
R01$20,200,353 · 8
U2C$2,740,445 · 2
T32$2,594,482 · 1
P01$987,361 · 1
R25$699,176 · 1
U18$492,407 · 1
Top collaborators
- John Christopher Chappell5 shared
- William H Guilford5 shared
- Joyce A Lloyd5 shared
- Peter Lobo5 shared
- Rahul Sharma5 shared
- John A Hossack3 shared
- Alexander L Klibanov2 shared
- Mitchell H. Rosner2 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Peter Lobo$3,360,926
- Carol M Rivera-Lopez$113,256
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationKidneyKidney DiseasesTissuesReperfusion InjuryCellsPathway InteractionsInjuryInflammatoryMediatingEnd Stage Renal FailureAcute Renal Failure With Renal Papillary NecrosisRenal IschemiaAttenuatedBaseProtective EffectProgramsMolecularDesignClinical TrialsIn VitroUniversitiesNovel TherapeuticsExposure To
Grant awards (102)
Proof of concept and feasibility in humans for pulsed ultrasound treatment to reduce inflammation and risk of AKI$315,327
R01 · FY2025 · DK · contact PI
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)$289,001
U2C · FY2025 · DK · contact PI
IGNITE KUH Administrative Core$271,561
U2C · FY2025 · DK · contact PI
Proof of concept and feasibility in humans for pulsed ultrasound treatment to reduce inflammation and risk of AKI$311,538
R01 · FY2024 · DK · contact PI
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)$260,101
U2C · FY2024 · DK · contact PI
IGNITE KUH Administrative Core$244,404
U2C · FY2024 · DK · contact PI
The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)$139,326
R25 · FY2024 · DK
Neuroimmune Regulation of Acute Kidney Injury$491,768
R01 · FY2023 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$489,079
R01 · FY2023 · DK · contact PI
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)$289,001
U2C · FY2023 · DK · contact PI
IGNITE KUH Administrative Core$271,559
U2C · FY2023 · DK · contact PI
The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)$139,326
R25 · FY2023 · DK
Neuroimmune Regulation of Acute Kidney Injury$491,768
R01 · FY2022 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$489,079
R01 · FY2022 · DK · contact PI
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)$289,000
U2C · FY2022 · DK · contact PI
IGNITE KUH Administrative Core$262,547
U2C · FY2022 · DK · contact PI
The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)$139,954
R25 · FY2022 · DK · contact PI
Neuroimmune Regulation of Acute Kidney Injury$491,768
R01 · FY2021 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$489,079
R01 · FY2021 · DK · contact PI
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)$289,000
U2C · FY2021 · DK · contact PI
IGNITE KUH Administrative Core$274,271
U2C · FY2021 · DK · contact PI
The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)$140,170
R25 · FY2021 · DK · contact PI
Neuroimmune Regulation of Acute Kidney Injury$491,768
R01 · FY2020 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$490,020
R01 · FY2020 · DK · contact PI
Kidney Disease and Inflammation$231,070
T32 · FY2020 · DK · contact PI
The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)$140,400
R25 · FY2020 · DK · contact PI
Neuroimmune Regulation of Acute Kidney Injury$491,766
R01 · FY2019 · DK · contact PI
Ultrasound for Non-Invasive Prevention of Acute Kidney Injury$483,641
R01 · FY2019 · DK · contact PI
Kidney Disease and Inflammation$229,303
T32 · FY2019 · DK · contact PI
Ultrasound for Non-Invasive Prevention of Acute Kidney Injury$483,641
R01 · FY2018 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$426,935
R01 · FY2018 · DK · contact PI
Kidney Disease and Inflammation$163,761
T32 · FY2018 · DK · contact PI
Ultrasound for Non-Invasive Prevention of Acute Kidney Injury$483,641
R01 · FY2017 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$426,935
R01 · FY2017 · DK · contact PI
Kidney Disease and Inflammation$168,870
T32 · FY2017 · DK · contact PI
Ultrasound for Non-Invasive Prevention of Acute Kidney Injury$483,641
R01 · FY2016 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$426,935
R01 · FY2016 · DK · contact PI
Leukocyte trafficking in acute renal failure$343,650
R01 · FY2016 · DK · contact PI
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.$217,815
U18 · FY2016 · EB · contact PI
Kidney Disease and Inflammation$151,818
T32 · FY2016 · DK · contact PI
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.$56,777
U18 · FY2016 · EB · contact PI
Ultrasound for Non-Invasive Prevention of Acute Kidney Injury$483,641
R01 · FY2015 · DK · contact PI
Sphingolipids in Acute Kidney Injury and Disease Progression$442,055
R01 · FY2015 · DK · contact PI
Leukocyte trafficking in acute renal failure$343,650
R01 · FY2015 · DK · contact PI
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.$217,815
U18 · FY2015 · EB · contact PI
Kidney Disease and Inflammation$194,512
T32 · FY2015 · DK · contact PI
Kidney Disease and Inflammation$61,105
T32 · FY2015 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$399,137
R01 · FY2014 · DK
Leukocyte trafficking in acute renal failure$343,650
R01 · FY2014 · DK · contact PI
Kidney Disease and Inflammation$148,088
T32 · FY2014 · DK · contact PI
Kidney Disease and Inflammation$58,227
T32 · FY2014 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$386,639
R01 · FY2013 · DK
Leukocyte trafficking in acute renal failure$343,650
R01 · FY2013 · DK · contact PI
Sphingolipids in Acute Kidney Injury$305,282
R01 · FY2013 · DK · contact PI
Nanotherapeutics for acute kidney injury$228,705
R21 · FY2013 · DK · contact PI
Kidney Disease and Inflammation$205,153
T32 · FY2013 · DK · contact PI
Kidney Disease and Inflammation$53,458
T32 · FY2013 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$404,439
R01 · FY2012 · DK
Sphingolipids in Acute Kidney Injury$316,355
R01 · FY2012 · DK · contact PI
Nanotherapeutics for acute kidney injury$196,667
R21 · FY2012 · DK · contact PI
Kidney Disease and Inflammation$193,458
T32 · FY2012 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$406,999
R01 · FY2011 · DK
Sphingolipids in Acute Kidney Injury$316,355
R01 · FY2011 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$315,531
R01 · FY2011 · DK · contact PI
Kidney Disease and Inflammation$196,185
T32 · FY2011 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$515,322
R01 · FY2010 · DK
Sphingolipids in Acute Kidney Injury$385,000
R01 · FY2010 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$318,718
R01 · FY2010 · DK · contact PI
MBF Bioscience and Zeiss Microscope System for Stereology and Tissue Morphology$278,312
S10 · FY2010 · RR · contact PI
Kidney Disease and Inflammation$102,701
T32 · FY2010 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$321,938
R01 · FY2009 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$110,601
R01 · FY2009 · DK · contact PI
Kidney Disease and Inflammation$98,362
T32 · FY2009 · DK · contact PI
Kidney Disease and Inflammation$28,270
T32 · FY2009 · DK · contact PI
Adenosine and Renal Injury$13,964
R01 · FY2009 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$321,938
R01 · FY2008 · DK · contact PI
Core--Inflammatory Assay$253,770
P01 · FY2008 · HL · contact PI
Adenosine and Renal Injury$237,560
R01 · FY2008 · DK · contact PI
Kidney Disease and Inflammation$84,118
T32 · FY2008 · DK · contact PI
Lysophosphatidic Acid Receptors and Acute Renal Failure$318,115
R01 · FY2007 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$308,728
R01 · FY2007 · DK · contact PI
Core--Inflammatory Assay$251,409
P01 · FY2007 · HL · contact PI
Adenosine and Renal Injury$242,408
R01 · FY2007 · DK · contact PI
Kidney Disease and Inflammation$109,350
T32 · FY2007 · DK · contact PI
Lysophosphatidic Acid Receptors and Acute Renal Failure$327,616
R01 · FY2006 · DK · contact PI
Leukocyte Trafficking in Acute Renal Failure$317,948
R01 · FY2006 · DK · contact PI
Adenosine and Renal Injury$249,648
R01 · FY2006 · DK · contact PI
Core--Inflammatory Assay$165,502
P01 · FY2006 · HL · contact PI
Kidney Disease and Inflammation$116,673
T32 · FY2006 · DK · contact PI
Lysophosphatidic Acid Receptors and Acute Renal Failure$335,500
R01 · FY2005 · DK
Leukocyte Trafficking in Acute Renal Failure$325,600
R01 · FY2005 · DK
Adenosine and Renal Injury$254,083
R01 · FY2005 · DK
Core--Inflammatory Assay$160,680
P01 · FY2005 · HL
Lysophosphatidic Acid Receptors and Acute Renal Failure$329,824
R01 · FY2004 · DK
Leukocyte Trafficking in Acute Renal Failure$325,600
R01 · FY2004 · DK
Core--Inflammatory Assay$156,000
P01 · FY2004 · HL
Leukocyte Trafficking in Acute Renal Failure$317,997
R01 · FY2003 · DK
ADENOSINE AND RENAL INJURY$222,740
R01 · FY2003 · DK
ADENOSINE AND RENAL INJURY$222,740
R01 · FY2002 · DK
ADENOSINE AND RENAL INJURY$222,740
R01 · FY2001 · DK
ADENOSINE AND RENAL INJURY$244,663
R01 · FY2000 · DK
NOVEL ADENOSINE 2A AGONISTS IN RENAL TISSUE PROTECTION$100,000
R41 · FY2000 · DK